DBT Bureau
Pune, 7 August 2026
Procter & Gamble Health Ltd. announced its financial results for the first quarter ended June 30, 2026. The Company delivered sales of ₹356 crores, up 7% versus a year ago, driven by strong brand fundamentals, superior retail execution and positive consumer response to new innovations. Reported Profit After Tax (PAT) stood at ₹96 crores, up 45% versus a year ago, led by growth in sales, strengthened supply chain and go-to-market capabilities, and one-time proceeds from the sale of an immovable asset. Operational Profit After Tax (PAT) was ₹72 crores, up 9% versus a year ago excluding the one-time proceeds.
Milind Thatte, Managing Director, P&G Health India, said, “We are happy to start the Financial Year 2026-2027 on a strong note, carrying forward the growth momentum of the previous fiscal. We delivered a strong quarter with sustained top-line and bottom-line growth. This growth is enabled by the consumer response to our science-backed superior innovations, new consumer communication initiatives and strengthened go-to-market and supply chain capabilities.
We are delivering balanced growth and value creation for all our stakeholders, driven by our strategy that is centred on a focused portfolio of quality, trusted and highly recommended brands where performance drives brand choice; superiority (across product, package, brand communication, retail execution and value), constructive disruption, productivity, and an agile accountable organization.”
